CASONATO, SANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.160
EU - Europa 1.116
AS - Asia 978
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 12.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.151
CN - Cina 572
VN - Vietnam 374
FI - Finlandia 269
SE - Svezia 238
DE - Germania 181
IT - Italia 155
GB - Regno Unito 105
UA - Ucraina 71
FR - Francia 25
IE - Irlanda 21
NL - Olanda 18
IN - India 17
BE - Belgio 12
CA - Canada 8
EU - Europa 7
MA - Marocco 7
TR - Turchia 5
AU - Australia 4
JP - Giappone 3
NZ - Nuova Zelanda 3
RO - Romania 3
AT - Austria 2
CH - Svizzera 2
DK - Danimarca 2
IR - Iran 2
PH - Filippine 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
HU - Ungheria 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.276
Salva come PNG Salva come JPEG
Città #
Fairfield 1.832
Chandler 1.057
Woodbridge 915
Ashburn 765
Houston 762
Seattle 648
Wilmington 639
Cambridge 618
Ann Arbor 599
Jacksonville 419
Dong Ket 374
Princeton 239
San Diego 198
Beijing 188
Medford 136
Roxbury 118
Nanjing 111
Helsinki 106
Padova 73
Boardman 68
Des Moines 61
New York 39
Shenyang 37
Hebei 30
Nanchang 30
Changsha 27
London 26
Norwalk 24
Jiaxing 23
Dublin 21
Guangzhou 20
Washington 19
Redwood City 17
Tianjin 12
Indiana 11
Los Angeles 11
Borås 10
Jinan 10
Hefei 9
Waanrode 8
Kunming 7
Tappahannock 7
Fuzhou 6
Guardiagrele 6
Kharkiv 6
Kilburn 6
Las Vegas 6
Trieste 6
Detroit 5
Southwark 5
Zhengzhou 5
Brussels 4
Dearborn 4
Florence 4
Nutley 4
Rabat 4
Chicago 3
Dallas 3
Hangzhou 3
Hounslow 3
Istanbul 3
Mestre 3
Ogden 3
Prescot 3
Pune 3
Rockville 3
Salé 3
Stockholm 3
Taizhou 3
Wandsworth 3
Auburn Hills 2
Augusta 2
Carmignano Di Brenta 2
Chiswick 2
Edinburgh 2
Falls Church 2
Haikou 2
Melbourne 2
Milan 2
New Bedfont 2
Ningbo 2
Parma 2
Phoenix 2
Rome 2
San Francisco 2
San Jose 2
Simi Valley 2
Tomblaine 2
Treviso 2
Vivaro 2
Wenzhou 2
Yellow Springs 2
Yenibosna 2
Abano Terme 1
Asir 1
Atlanta 1
Auckland 1
Belgrade 1
Bratislava 1
Brendola 1
Totale 10.490
Salva come PNG Salva come JPEG
Nome #
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. 178
Diagnosis and complications of Cushing's disease: gender-related differences. 147
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. 142
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 123
Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue 122
Type IIB von Willebrand Factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets 120
Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease 120
FACTOR-VIII VONWILLEBRAND-FACTOR ABNORMALITIES DURING L-ASPARAGINASE TREATMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA 118
New insight into the Hypercoagulability of Cushing's Syndrome 117
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 116
Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature. 114
Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease 114
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosis 112
Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor 111
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. 110
Bernard-Soulier Syndrome: diagnosis by ELISA method using monoclonal antibodies in 2 new unrelated patients 108
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 108
The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity 107
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 105
Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy 105
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 104
Identifying type Vicenza von Willebrand disease 103
A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease 102
Severe, recessive type 1 is a discrete form of von Willebrand disease: The lesson learned from the c.1534-3C>A von Willebrand factor mutation 101
The significance of thrombocytosis in old age 99
The significance of plasma and /or platelet activated products after apheresis procedures 99
A model-based approach to the automatic diagnosis of von Willebrand disease 97
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly 97
Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases 97
von Willebrand factor abnormalities in aortic valve stenosis:pathophysiology and impact on bleeding. 97
Normal and low molecular weight heparins: interaction with human platelets 94
Cryptic noncanonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor 93
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. 92
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). 91
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. 90
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 90
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 90
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. 89
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 89
The elusive and heterogeneous pattern of type 2M von Willebrand disease: A diagnostic challenge 88
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 85
Clinical significance of beta-thromboglobulin in patients with high platelet count 85
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. 84
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 83
Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variants. 82
The evaluation of factor VIII antigen by means of a simple slide test. 82
C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor 82
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 82
Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activation. 81
A model-based support for diagnosing von Willebrand disease 81
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 81
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor. 80
Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration. 80
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis 80
Biochemical markers of endothelial activation in primary hyperparathyroidism 80
The effect of anticoagulant mixtures on BTG and PF4 levels. 79
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. 79
A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease 79
A frequent factor XII gene mutation in Hageman trait. 78
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 78
Type 2N von Willebrand disease: Characterization and diagnostic difficulties 77
Coagulopathy in Cushing's syndrome. 76
Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation 76
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 75
A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy. 75
Type 3 von Willebrand disease mistaken for moderate haemophilia A: a lesson still to be learned 75
Uneventful coronary artery bypass surgery without prophylatic replacement therapy in a patient with a novel heterozygous FVII gene deletion 75
Type I Padua: a new variant of von Willebrand's disease. 74
Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. 74
Which assay is the most suitable to investigate von Willebrand factor functional activity? 74
In vivo platelet release reaction in patients with heart valve prosthesis. 74
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 74
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. 73
Von Willebrand factor abnormalities in IgA nephropathy. 73
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. 73
A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. 73
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene. 73
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 73
The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. 72
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. 72
Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing? 72
Effect of heparin and aspirin on platelet and clotting activation during leukapheresis 72
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 72
Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome 72
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. 71
Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. 71
Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature. 71
Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis. 71
A study of platelet function and morphology in a new family with May-Hegglin anomaly. 70
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 70
Platelet aggregation and thrombopheresis in thrombocythemia 70
Towards model-based diagnosis of von Willebrand disease 70
Type 1 von Willebrand disease due to a vicinal cysteine loss (p.C524Y) disclosed after a thrombotic episode 70
von Willebrand disease investigated by two novel RFLPs. 69
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 69
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. 69
Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28. 67
Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys236Phe mutation in the B2 domain 67
On the release of von Willebrand factor from endothelial cells after venous occlusion. 67
Demonstration that venous occlusion fails to release von Willebrand factor multimers. 66
Totale 8.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.428
article - articoli 39.082
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 798
Totale 80.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.139 0 0 0 0 0 0 0 0 0 234 491 414
2019/20202.762 443 82 58 173 294 206 252 329 331 257 193 144
2020/20211.894 86 94 54 139 90 148 80 143 251 175 165 469
2021/20222.464 74 256 332 219 69 166 137 310 74 38 302 487
2022/20231.986 387 206 85 238 300 264 4 138 230 8 103 23
2023/2024612 48 114 110 70 70 96 54 28 7 15 0 0
Totale 12.379